当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Myles R. McCrary
Since last many times, an emotional quantum of data has been generated regarding the introductory in vitro and in vivo biology of neural stem cells (NSCs) and there's much far hope for the success in cell relief curatives for severa mortal neurodegenerative conditions and stroke. The discovery of adult neurogenesis (the endogenous product of new neurons) in the mammalian brain further than 40 times ago has redounded in a wealth of knowledge about stem cells biology in neuroscience exploration. Colorful studies have done in hunt of a suitable source for NSCs which could be used in beast models to understand the introductory and transplantation biology before treating to mortal. The difficulties in segregating pure population of NSCs limit the study of neural stem geste and factors that regulate them [1]. Several studies on mortal fetal brain and spinal cord deduced NSCs in beast models have shown some intriguing results for cell relief curatives in numerous neurodegenerative conditions and stroke models. Also the styles and conditions used for in vitro culture of these cells give an important base for their connection and particularity in a definite target of the complaint. Colorful important developments and variations have been made in stem cells exploration which is demanded to be more specified and registration in clinical studies using advanced approaches. This review explains about the current perspectives and suitable sources for NSCs insulation, characterization, in vitro proliferation and their use in cell relief curatives for the treatment of colorful neurodegenerative conditions and strokes [2].